Transfusion Flashcards
what are the 4 indications for transfusion
- anemia
- secondary coagulopathy
- thrombocytopenia
- hypoproteinemia (rare)
transfusing specific components vs whole blood
only want to transfuse the products that the patient needs
- packed RBCs
- platelets
- plasma
RBC transfusion indication
anemia
transfusion triggers for RBCs
- PCV = 20-22%
- ongoing losses (transfuse sooner)
- chronicity
- clinical response to anemia (transfuse later if patient compensating)
- underlying/concurrent disease
RBC products
- fresh whole blood
- stored whole blood
- packed RBCs
transfusion volume - RBCs
goal: PCV = 25%
pRBCs: 1-1.5 mL/kg
whole blood: 2 mL/kg
(to increase PCV by 1%)
indications for plasma transfusion
- acquired secondary coagulopathy w/ serious bleeding (rodenticide, liver failure, heat stroke, DIC)
- bleeding w/ congenital coagulopathy
- clinical signs of secondary coagulopathy
- coagulation testing - prolonged PT/PTT, ACT, etc
products for transfusing plasma
- fresh plasma: all factors
- fresh frozen plasma: all factors
- frozen plasma: stable factors (vit K dependent)
- cryoprecipitate: labile factors
transfusion volume - plasma
10-15 mL/kg minimum
titrate to effect
indications for platelet transfusion
- severe thrombocytopenia w/ severe hemorrhage (<10,000)
- moderate thrombocytopenia w/ planned invasive procedure (>50,000)
- massive transfusions
- thrombocytopathy
platelet transfusion products
SHORT half life
- fresh whole blood
- platelet rich plasma
- platelet concentrate
- cryopreserved platelets
transfusion volume - platelets
1 unit/kg
titrate to effect
is it common to transfuse albumin?
no
what is blood type determined by
antigens present on RBC surface
genetically determined
species specific
antigenic in individuals that lack the same marker
what is the major dog blood type antigen
DEA-1
strongly antigenic
generates a strong alloantibody response AFTER sensitization
do dogs have naturally occurring antibodies against DEA-1
NO
DEA-1 negative dogs do NOT have natural antibodies against DEA-1
will develop antibodies AFTER sensitization (ex. previous transfusion with DEA-1 blood)
DEA-1 negative donors and recipients
donate to DEA-1 + and -
receive from DEA-1 - only